Dynavax Technologies logo

Dynavax Technologies Share Price (NASDAQ: DVAX)

$10.07

-0.2

(-1.95%)

Live

Last updated on

Check the interactive Dynavax Technologies Stock chart to analyse performance

Dynavax Technologies stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$10.07
    Today's High:$10.21

    Day's Volatility :1.37%

  • 52 Weeks Low:$9.22
    52 Weeks High:$14.63

    52 Weeks Volatility :36.98%

Dynavax Technologies Stock Returns

PeriodDynavax Technologies CorporationSector (Health Care)Index (Russel 2000)
3 Months
5.01%
3.1%
0.0%
6 Months
-25.45%
-8.4%
0.0%
1 Year
-8.7%
-12.6%
0.0%
3 Years
-9.35%
7.9%
-6.1%

Dynavax Technologies Corporation Key Stats

Check Dynavax Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$10.27
Open
$10.19
Today's High
$10.21
Today's Low
$10.045
Market Capitalization
$1.2B
Today's Volume
$1.9M
52 Week High
$14.63
52 Week Low
$9.22
Revenue TTM
$316.3M
EBITDA
$12.9M
Earnings Per Share (EPS)
$-0.45
Profit Margin
-16.67%
Quarterly Earnings Growth YOY
0.76%
Return On Equity TTM
-9.28%

Stock Returns calculator for Dynavax Technologies Stock including INR - Dollar returns

The Dynavax Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dynavax Technologies investment value today

Current value as on today

₹94,609

Returns

₹5,391

(-5.39%)

Returns from Dynavax Technologies Stock

₹10,568 (-10.57%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Dynavax Technologies Stock

-25%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Dynavax Technologies Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Dynavax Technologies Corporation

  • Name

    Holdings %

  • BlackRock Inc

    17.31%

  • Deep Track Capital, LP

    15.18%

  • Vanguard Group Inc

    7.19%

  • State Street Corp

    5.79%

  • TANG CAPITAL MANAGEMENT LLC

    4.90%

  • Chicago Capital LLC

    4.46%

Analyst Recommendation on Dynavax Technologies Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Dynavax Technologies(by analysts ranked 0 to 5 stars)

Dynavax Technologies Share Price Target

What analysts predicted

Upside of 126.42%

Target:

$22.80

Current:

$10.07

Dynavax Technologies share price target is $22.80, a slight Upside of 126.42% compared to current price of $10.07 as per analysts' prediction.

Dynavax Technologies Stock Insights

  • Price Movement

    In the last 1 month, DVAX stock has moved down by -8.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 68.16M → 95.44M (in $), with an average increase of 28.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -96.09M → 18.72M (in $), with an average increase of 613.3% per quarter
  • DVAX vs NBIX (1 yr)

    In the last 1 year, Neurocrine Biosciences Inc. has given 8.2% return, outperforming this stock by 16.9%
  • DVAX vs HLN (3 yr)

    In the last 3 years, Haleon Plc Spon Ads has given 31.9% return, outperforming this stock by 38.4%
  • Price to Sales

    ForDVAX every $1 of sales, investors are willing to pay $4.1, whereas for Neurocrine Biosciences Inc., the investors are paying $5.5 for every $1 of sales.

Dynavax Technologies Corporation Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$277.2M
↑ 19.36%
Net Income
$27.3M
↓ 527.44%
Net Profit Margin
9.85%
↑ 12.6%

Dynavax Technologies Technicals Summary

Sell

Neutral

Buy

Dynavax Technologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Dynavax Technologies Corporation Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Dynavax Technologies Corporation logo
-7.97%
-25.45%
-8.7%
-9.35%
26.76%
Haleon Plc Spon Ads logo
0.52%
-4.81%
-3.96%
59.37%
30.77%
United Therapeutics Corporation logo
8.95%
-4.02%
-14.72%
40.29%
72.75%
Zoetis Inc. logo
4.01%
-7.46%
-15.38%
-1.47%
-3.33%
Neurocrine Biosciences Inc. logo
1.61%
17.05%
8.2%
34.52%
19.36%

About Dynavax Technologies Corporation

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Organization
Dynavax Technologies
Employees
405
CEO
Mr. Ryan Spencer
Industry
Health Technology

Key Management of Dynavax Technologies Corporation

NameTitle
Mr. Ryan Spencer
CEO & Director
Mr. David F. Novack
President & COO
Ms. Kelly MacDonald CPA
Senior VP & CFO
Mr. John L. Slebir
Senior VP & General Counsel
Dr. Robert Janssen M.D.
Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory Affairs
Mr. Joseph Metzinger
VP & Chief Accounting Officer
Mr. Jeff P. Coon
Senior VP & Chief Human Resources Officer
Mr. Paul Cox
VP of Investor Relations & Corporate Communications
Mr. Donn Casale
Senior VP & Chief Commercial Officer
Dr. Dong Yu
Senior Vice President of Research

Important FAQs about investing in DVAX Stock from India :

What is Dynavax Technologies share price today?

Dynavax Technologies share price today is $10.07 as on . Dynavax Technologies share today touched a day high of $10.21 and a low of $10.07.

What is the 52 week high and 52 week low for Dynavax Technologies share?

Dynavax Technologies share touched a 52 week high of $14.63 and a 52 week low of $9.22. Dynavax Technologies stock price today i.e. is trending at $10.07, lower by 31.17% versus the 52 week high.

How to invest in Dynavax Technologies Stock (DVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dynavax Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dynavax Technologies Shares that will get you 0.1490 shares as per Dynavax Technologies share price of $10.07 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Dynavax Technologies Stock (DVAX) from India?

Indian investors can start investing in Dynavax Technologies (DVAX) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Dynavax Technologies stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Dynavax Technologies share’s latest price of $10.07 as on August 30, 2025 at 1:29 am IST, you will get 0.9930 shares of Dynavax Technologies. Learn more about fractional shares .

What are the returns that Dynavax Technologies has given to Indian investors in the last 5 years?

Dynavax Technologies stock has given 26.76% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?